Journals / Turkish Journal of Orthodontics / 2022 / Cilt: 35 - Sayı: 1

Orofacial Manifestations Associated with Muscular Dystrophies: A Review

Pages
67–73
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It was found that all the muscular dystrophies studied showed altered craniofacial morphology, with malocclusion as the most consistent clinical characteristic.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The aim of this review is to evaluate the developmental, functional, and morphological aspects of the craniofacial complex in patients with myotonic dystrophy type 1 (DM1), Facioscapulohumeral muscular dystrophy (FSHD), and Duchenne muscular dystrophy (DMD).
📊
Key Findings & Data:Particularly DM1 patients, who are the most studied, showed significant vertical aberration and post-normal occlusion.
💡
Conclusion & Impact:It was found that all the muscular dystrophies studied showed altered craniofacial morphology, with malocclusion as the most consistent clinical characteristic.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

The aim of this review is to evaluate the developmental, functional, and morphological aspects of the craniofacial complex in patients with myotonic dystrophy type 1 (DM1), Facioscapulohumeral muscular dystrophy (FSHD), and Duchenne muscular dystrophy (DMD). The degree of disease onset and severity varied from patient to patient, and most parameters indicated a greater degree of deterioration in older patients. It was found that all the muscular dystrophies studied showed altered craniofacial morphology, with malocclusion as the most consistent clinical characteristic. Particularly DM1 patients, who are the most studied, showed significant vertical aberration and post-normal occlusion. DMD patients are reported mainly with altered dental arch dimensions which influence functional capacities. Data for FSHD patients are very limited, but facial asymmetry and muscular weakness appear to be the most prominent findings. Patients with muscular dystrophies present deviations in growth and development as well as in orofacial morphology. Increased prevalence of malocclusions, of both skeletal and dental origins, characterize patients with muscular dystrophies. Different dentofacial characteristics are reported among patients with different types of muscular dystrophies. Further research is needed to clarify the orofacial phenotypic expression of muscular dystrophies.

🔖

Cite This Article

PAPAEFTHYMIOU, P., ÖZDEMİR, F., KEKOU, K. (2022). Orofacial Manifestations Associated with Muscular Dystrophies: A Review. Turkish Journal of Orthodontics, Cilt: 35 - Sayı: 1, 67–73. https://ajindex.com/articles/414293

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Mercuri E, Bönnemann CG, Muntoni F. Muscular dystrophies. Lancet. 2019
  2. 394(10213):2025-2038. [CrossRef] 2. Hall BK, Herring SW. Paralysis and growth of the musculoskeletal system in the embryonic chick. J Morphol. 1990
  3. 206(1):45-56. [CrossRef] 3. Rot-Nikcevic I, Reddy T, Downing KJ, et al. Myf5−/−:MyoD−/− amyogenic fetuses reveal the importance of early contraction and static loading by striated muscle in mouse skeletogenesis. Dev Genes Evol. 2006
  4. 216(1):1-9. [CrossRef] 4. Almontashiri NM. Dystrophin-associated muscular dystrophies: learning from genetics to guide therapeutics. J Musculoskelet Surg Res. 2019
  5. 3(3):241-244. [CrossRef] 5. Day JW, Roelofs R, Leroy B, et al. Clinical and genetic characteristics of a five-generation family with a novel form of myotonic dystrophy (DM2). Neuromuscul Disord. 1999
  6. 9(1):19-27. [CrossRef] 6. Shaw DJ, Harper PS. Myotonic dystrophy: developments in molecular genetics. Br Med Bull. 1989
  7. 45(3):745-759. [CrossRef] 7. Brook JD, McCurrach ME, Harley HG, et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell. 1992
  8. 68(4):799-808. [CrossRef] 8. Reardon W, Harper PS. Advances in myotonic dystrophy: a clinical and genetic perspective. Curr Opin Neurol Neurosurg. 1992
  9. 5(5):605-609. 9. Harper PS, Harley HG, Reardon W, Shaw DJ. Anticipation in myotonic dystrophy: new light on an old problem. Am J Hum Genet. 1992
  10. 51(1):10-16. 10. Skoczylas LJ, Langlais RP, Young RS. Myotonic dystrophy: review of the literature and new radiographic findings. Dentomaxillofac Radiol. 1985
  11. 14(2):101-108. [CrossRef] 11. Kiliaridis S, Engvall M, Tzakis MG. Ultrasound imaging of the masseter muscle in myotonic dystrophy patients. J Oral Rehabil. 1995
  12. 22(8):619-625. [CrossRef] 12. Thayer HH, Crenshaw J. Oral manifestations of myotonic muscular dystrophy: report of case. J Am Dent Assoc. 1966
  13. 72(6):1405-1411. [CrossRef] 13. Deenen JC, Arnts H, van der Maarel SM, et al. Population-based incidence and prevalence of facioscapulohumeral dystrophy. Neurology. 2014
  14. 83(12):1056-1059. [CrossRef] 14. Wagner KR. Facioscapulohumeral muscular dystrophies. Continuum (Minneap Minn). 2019
  15. 25(6):1662-1681. [CrossRef] 15. Tonini MM, Passos-Bueno MR, Cerqueira A, et al. Asymptomatic carriers and gender differences in facioscapulohumeral muscular dystrophy (FSHD). Neuromuscul Disord. 2004
  16. 14(1):33-38. [CrossRef] 16. Gaillard MC, Roche S, Dion C, et al. Differential D